Prostate News Archive
23-Nov-2011
Prostate Cancer Drug Delays Bone Cancer Spread
A new drug administered to prostate cancer patients has been shown to delay the spread of cancer to the bones, according to a new study published in the Lancet. Prostate Cancer May Be Linked to Birth Control Pill in Water Supply
Countries where the highest numbers of women use oral contraceptives have the highest rates of death from prostate cancer, a new study finds. Prostate cancer tied to birth-control pills, but why?
New research shows high rates of prostate cancer in nations where women rely on oral contraceptives Future prostate cancer treatments might be guided by math
Scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their tumors. These decisions would apply to treatment of cancer that has already spread beyond the prostate gland or that has recurred after initial ... Celgene ends Revlimid prostate cancer trial
Celgene Corp. said Tuesday it is ending a late-stage clinical study of its drug Revlimid as a treatment for prostate cancer.
Back to Prostate News Archive
